Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB
· Real-Time Price · USD
5.88
-0.04 (-0.68%)
At close: Sep 26, 2025, 10:58 AM
-0.68% (1D)
| Bid | 5.86 |
| Market Cap | 457.87M |
| Revenue (ttm) | 3.12M |
| Net Income (ttm) | -154.08M |
| EPS (ttm) | -2.65 |
| PE Ratio (ttm) | -2.22 |
| Forward PE | -3.25 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.89 |
| Volume | 183,784 |
| Avg. Volume (20D) | 1,353,844.2 |
| Open | 5.90 |
| Previous Close | 5.92 |
| Day's Range | 5.77 - 6.03 |
| 52-Week Range | 2.41 - 7.57 |
| Beta | 2.55 |
| Ex-Dividend Date | n/a |
About SLDB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLDB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLDB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+10.6%
Solid Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
2 months ago
+8.51%
Solid Biosciences shares are trading higher after the company announced it received FDA Fast Track Designation status for SGT-501 gene therapy.
